Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.
Saved in:
| Title: | Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. |
|---|---|
| Authors: | Kandeil A; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Mostafa A; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Hegazy RR; Department of Pharmacology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., El-Shesheny R; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., El Taweel A; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Gomaa MR; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Shehata M; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Elbaset MA; Department of Pharmacology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Kayed AE; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Mahmoud SH; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Moatasim Y; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Kutkat O; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Yassen NN; Department of Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Shabana ME; Department of Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., GabAllah M; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Kamel MN; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Abo Shama NM; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., El Sayes M; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt., Ahmed AN; Department of Clinical & Chemical Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Elalfy ZS; Department of Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Mohamed BM; Department of Pharmacology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Abd El-Fattah SN; Department of Clinical & Chemical Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., El Hariri HM; Department of Community Medicine, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Abdel Kader M; Department of Clinical & Chemical Pathology, Medical Division, National Research Centre, Cairo, Giza 12622, Egypt., Azmy O; Reproductive Health Department, Medical Research Division, National Research Centre, Giza 12622, Egypt., Kayali G; Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas, Houston, TX 77030, USA.; Human Link, Dubai, United Arab Emirates., Ali MA; Center of Scientific Excellence for Influenza Virus, Environmental Research Division, National Research Centre, Giza 12622, Egypt. |
| Source: | Vaccines [Vaccines (Basel)] 2021 Mar 03; Vol. 9 (3). Date of Electronic Publication: 2021 Mar 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
